Patient Burden and Insights in COPD: A Survey Analysis.

David M Mannino¹, Sarina Trac², Jai Seth², Amy Dixon³, Kavita Aggarwal³, Brooks Kuhn⁴

¹COPD Foundation, Miami, Florida, United States.

²Phreesia Life Sciences, Wilmington, Delaware, United States.

³Verona Pharma, Raleigh, North Carolina, United States.

⁴Davis School of Medicine, University of California, Sacramento, California, United States.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) affects millions of people and is associated with significant morbidity and mortality. Patients experience a high symptom burden with impacts on quality of life, which have not been well quantified. METHODS: Phreesia's PatientInsightsquantitative survey was offered in January 2025 to patients with COPD during their check-in process for heal…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.